0.1%, 0.2% Diclazuril premix
.png)
.png)
.png)
.png)
Mode of action and characteristics
Diclazuril is a triazine broad-spectrum anticoccidial drug, which mainly inhibits the proliferation of sporozoites and schizonts. The schizonts proliferate, and the coccidia's activity peaks at the sporozoites and first-generation schizonts (ie, the first 2 days of the coccidial life cycle). It has coccidicidal effect and is effective for all stages of coccidiogenesis. It has a good effect on the tender, heap-shaped, poisonous, Brucella, giant and other Eimeria coccidia, duck and rabbit coccidia. After diclazuril is mixed with chickens, a small part is absorbed by the digestive tract, but because the dosage is small, the total absorption is very small, so there is little drug residue in the tissue. Mixed feeding at a dose of 1 mg/kg, on the 7th day after the last administration, the average residual amount in chicken tissue was measured to be less than 0.063 mg/kg. Diclazuril is less toxic and safe for livestock and poultry. Long-term use of this product is easy to induce drug resistance, so it should be used for shuttle or short-term use. The effect of this product is short, and the effect basically disappears after 2 days of drug withdrawal.
Dosage
based on this product. Mixed feeding: 500g of poultry and rabbits per 1000kg of feed.
Precautions
(1) Forbidden during laying hens
(2) The efficacy period of this product is short, the anti-coccidial effect is obviously weakened after 1 day of drug withdrawal, and the effect basically disappears after 2 days. Therefore, continuous medication must be used to prevent the recurrence of coccidiosis.
(3) The mixture concentration of this product is extremely low, and the medicinal materials should be fully mixed, otherwise the curative effect will be affected.
Main Ingredient
Diclazuril
Uses
Anticoccidial. For the prevention of poultry and rabbit coccidia
Withdrawal period
5 days for chickens and 14 days for rabbits.
Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation based veterinary enterprise, there are 65 technical professionals. Veyong has two production bases: Shijiazhuang and Ordos, of which the Shijiazhuang base covers an area of 78,706 m2, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 11 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own- label preparations, and OEM & ODM service.
Veyong attaches great importance to the management of EHS(Environment, Health& Safety) system, and obtained the ISO14001 and OHSAS18001 certificates. Veyong has been listed in the strategic emerging industrial enterprises in Hebei Province and can ensure the continuous supply of products.
Veyong established the complete quality management system, obtained the ISO9001 certificate, China GMP certificate, Australia APVMA GMP certificate, Ethiopia GMP certificate, Ivermectin CEP certificate, and passed US FDA inspection. Veyong has professional team of registeration, sales and technical service, our company has gained reliance and support from numerous customers by excellent product quality, high-quality pre-sales and after-sales service, serious and scientific management. Veyong has made long term cooperation with many internationally known animal pharmaceutical enterprises with products exported to the Europe, South America, Middle East, Africa, Asia, etc. more than 60 countries and regions.
